A detailed history of Nisa Investment Advisors, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,535 shares of EDIT stock, worth $1,934. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,535
Previous 1,846 16.85%
Holding current value
$1,934
Previous $8,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$3.39 - $5.96 $1,054 - $1,853
-311 Reduced 16.85%
1,535 $5,000
Q2 2024

Jul 19, 2024

BUY
$4.67 - $7.28 $1,531 - $2,387
328 Added 21.61%
1,846 $8,000
Q1 2024

May 01, 2024

BUY
$7.03 - $11.07 $864 - $1,361
123 Added 8.82%
1,518 $11,000
Q4 2023

Jan 25, 2024

BUY
$6.25 - $11.11 $62 - $111
10 Added 0.72%
1,395 $14,000
Q3 2023

Nov 02, 2023

SELL
$6.92 - $9.31 $166 - $223
-24 Reduced 1.7%
1,385 $10,000
Q2 2023

Aug 11, 2023

SELL
$6.36 - $11.47 $6,716 - $12,112
-1,056 Reduced 42.84%
1,409 $11,000
Q1 2023

May 02, 2023

SELL
$7.03 - $11.53 $4,745 - $7,782
-675 Reduced 21.5%
2,465 $18,000
Q4 2022

Feb 02, 2023

SELL
$8.32 - $13.21 $257 - $409
-31 Reduced 0.98%
3,140 $28,000
Q3 2022

Nov 07, 2022

SELL
$12.16 - $19.42 $352 - $563
-29 Reduced 0.91%
3,171 $40,000
Q2 2022

Aug 03, 2022

SELL
$9.99 - $21.35 $155,844 - $333,060
-15,600 Reduced 82.98%
3,200 $38,000
Q1 2022

Apr 29, 2022

SELL
$14.08 - $27.63 $4,364 - $8,565
-310 Reduced 1.62%
18,800 $358,000
Q4 2021

Feb 03, 2022

SELL
$26.55 - $40.57 $3,265 - $4,990
-123 Reduced 0.64%
19,110 $364,000
Q3 2021

Oct 18, 2021

SELL
$39.27 - $72.94 $67,858 - $126,040
-1,728 Reduced 8.24%
19,233 $790,000
Q2 2021

Aug 06, 2021

SELL
$31.29 - $56.64 $26,596 - $48,144
-850 Reduced 3.9%
20,961 $1.19 Million
Q1 2021

Apr 26, 2021

SELL
$39.71 - $90.58 $41,695 - $95,109
-1,050 Reduced 4.59%
21,811 $916,000
Q4 2020

Jan 25, 2021

BUY
$27.07 - $84.35 $102,622 - $319,770
3,791 Added 19.88%
22,861 $1.6 Million
Q3 2020

Oct 20, 2020

BUY
$28.06 - $37.16 $51,911 - $68,746
1,850 Added 10.74%
19,070 $535,000
Q2 2020

Jul 27, 2020

BUY
$18.5 - $34.34 $1,110 - $2,060
60 Added 0.35%
17,220 $509,000
Q1 2020

Apr 17, 2020

SELL
$14.88 - $32.78 $54,312 - $119,647
-3,650 Reduced 17.54%
17,160 $340,000
Q4 2019

Jan 17, 2020

SELL
$19.49 - $32.63 $3,897 - $6,526
-200 Reduced 0.95%
20,810 $616,000
Q3 2019

Oct 17, 2019

BUY
$22.49 - $26.81 $4,498 - $5,362
200 Added 0.96%
21,010 $478,000
Q2 2019

Jul 12, 2019

SELL
$20.48 - $27.76 $1.02 Million - $1.39 Million
-50,000 Reduced 70.61%
20,810 $515,000
Q4 2018

Jan 17, 2019

SELL
$18.19 - $31.79 $9,095 - $15,895
-500 Reduced 0.7%
70,810 $1.61 Million
Q3 2018

Oct 16, 2018

BUY
$27.65 - $38.39 $3,041 - $4,222
110 Added 0.15%
71,310 $2.27 Million
Q2 2018

Jul 19, 2018

SELL
$31.4 - $41.01 $6,280 - $8,202
-200 Reduced 0.28%
71,200 $2.55 Million
Q4 2017

Jan 12, 2018

BUY
$21.89 - $31.34 $1.08 Million - $1.54 Million
49,200 Added 221.62%
71,400 $2.19 Million
Q3 2017

Oct 13, 2017

BUY
$15.81 - $24.01 $350,982 - $533,022
22,200
22,200 $533,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $86.6M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.